Bruker (NASDAQ: BRKR) and Agilent Technologies (NYSE:A) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability and earnings.
Valuation and Earnings
This table compares Bruker and Agilent Technologies’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Bruker||$1.77 billion||2.65||$78.60 million||$0.49||61.29|
|Agilent Technologies||$4.47 billion||5.04||$684.00 million||$0.59||118.47|
Institutional and Insider Ownership
65.5% of Bruker shares are held by institutional investors. 35.2% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This table compares Bruker and Agilent Technologies’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent ratings and price targets for Bruker and Agilent Technologies, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Bruker presently has a consensus target price of $32.08, suggesting a potential upside of 6.84%. Agilent Technologies has a consensus target price of $70.59, suggesting a potential upside of 0.99%. Given Bruker’s higher possible upside, research analysts plainly believe Bruker is more favorable than Agilent Technologies.
Risk and Volatility
Bruker has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.
Bruker pays an annual dividend of $0.16 per share and has a dividend yield of 0.5%. Agilent Technologies pays an annual dividend of $0.60 per share and has a dividend yield of 0.9%. Bruker pays out 32.7% of its earnings in the form of a dividend. Agilent Technologies pays out 101.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Agilent Technologies has increased its dividend for 2 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Agilent Technologies beats Bruker on 10 of the 17 factors compared between the two stocks.
Bruker Company Profile
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.
Agilent Technologies Company Profile
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.